ALEX GORSKY

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Apple Inc.

Filing Date Source Excerpt
2022-01-06 Alex Gorsky, 61, is the Executive Chairman of Johnson & Johnson, a global healthcare products company.
2023-01-12 Mr. Gorsky, 62, has served as the Executive Chairman of Johnson & Johnson, a global healthcare products company, since January 2022.
2024-01-11 Mr. Gorsky brings to the Board executive leadership experience, as well as brand marketing expertise and extensive experience in the fields of health and technology.
2025-01-10 Alex Gorsky brings to the Board executive leadership experience, as well as brand marketing expertise and extensive experience in the fields of health and technology.

INTERNATIONAL BUSINESS MACHINES CORP

Filing Date Source Excerpt
2019-03-11 Mr. Gorsky, 58, joined Johnson & Johnson in 1988. He was named company group chairman of the Johnson & Johnson pharmaceutical business in Europe, the Middle East and Africa in 2003. Mr. Gorsky left Johnson & Johnson in 2004 to join Novartis Pharmaceuticals Corporation. Mr. Gorsky returned to Johnson & Johnson in 2008 as company group chairman for Ethicon. He was named chief executive officer and joined the board of directors in April 2012, and was named chairman in December 2012. Committees: Executive Compensation & Management Resources (Chair), Executive, Executive Committee. Compensation: Fees Earned or Paid in Cash $328,389, All Other Compensation $47,506, Total $375,895.
2020-03-09 Director since: 2014 Age: 59 Committees: Executive, Compensation & Management Resources (Chair), Executive Alex Gorsky Chairman and Chief Executive Officer, Johnson & Johnson
2021-03-08 Chairman and Chief Executive Officer, Johnson & Johnson.
2022-03-07 Alex Gorsky, 61, Executive Chairman and Retired CEO, Johnson & Johnson, Director since 2014, Committees: Executive Compensation and Management Resources, Executive. 2021 Director Compensation Table shows total $564,084.
2023-03-06 Mr. Gorsky, 62, is the former chairman and chief executive officer of Johnson & Johnson, and one of just seven leaders to have served in the dual role of chairman and chief executive officer since the company was listed on the New York Stock Exchange in 1944. He joined Johnson & Johnson in 1988 as a sales representative with Janssen Pharmaceutica. In 2003, he was named company group chairman of the Johnson & Johnson pharmaceutical business in Europe, the Middle East and Africa. Mr. Gorsky left Johnson & Johnson in 2004 to join the Novartis Pharmaceuticals Corporation, where he served as head of the company’s pharmaceutical business in North America. Mr. Gorsky returned to Johnson & Johnson in 2008 as company group chairman for Ethicon. In early 2009, he was appointed worldwide chairman of the Surgical Care Group and member of the executive committee. In September 2009, he was appointed worldwide chairman of the Medical Devices and Diagnostics Group, and became vice chairman of the executive committee in January 2011. He was named chief executive officer and joined the board of directors in April 2012, and was named chairman of the board of directors in December 2012. Mr. Gorsky remained chief executive officer until he transitioned to executive chairman at the end of 2021. He currently sits on the boards of Apple, JPMorgan Chase and NewYork-Presbyterian Hospital, and the Travis Manion Foundation, and serves on the Wharton School of the University of Pennsylvania Board of Advisors.
2024-03-11 Alex Gorsky Former Chairman and Chief Executive Officer, Johnson & Johnson, a global healthcare products company Director since: 2014 Age: 63 Committee: Executive ... 2023 Director Compensation Table Name Alex Gorsky ... Fees Earned or Paid in Cash ($) 400,000 All Other Compensation ($) 169,758 Total ($) 569,758
2025-03-10 Mr. Gorsky, 64, is the former chairman and chief executive officer of Johnson & Johnson, and one of just seven leaders to have served in the dual role of chairman and chief executive officer since the company was listed on the New York Stock Exchange in 1944. He joined Johnson & Johnson in 1988 as a sales representative with Janssen Pharmaceutica. In 2003, he was named company group chairman of the Johnson & Johnson pharmaceutical business in Europe, the Middle East and Africa. Mr. Gorsky left Johnson & Johnson in 2004 to join the Novartis Pharmaceuticals Corporation, where he served as head of the company’s pharmaceutical business in North America. Mr. Gorsky returned to Johnson & Johnson in 2008 as company group chairman for Ethicon. In early 2009, he was appointed worldwide chairman of the Surgical Care Group and member of the executive committee. In September 2009, he was appointed worldwide chairman of the Medical Devices and Diagnostics Group and became vice chairman of the executive committee in January 2011. He was named chief executive officer and joined the board of directors in April 2012, and was named chairman of the board of directors in December 2012. Mr. Gorsky remained chief executive officer until he transitioned to executive chairman at the end of 2021. He currently sits on the boards of Apple, JPMorgan Chase and the Travis Manion Foundation, and serves on the Board of Advisors for the Wharton School of the University of Pennsylvania.

JOHNSON & JOHNSON

Filing Date Source Excerpt
2017-03-15 Chairman, Board of Directors; Chief Executive Officer, Johnson & Johnson
2018-03-14 Chairman, Board of Directors; Chief Executive Officer, Johnson & Johnson
2019-03-13 Chairman and Chief Executive Officer, Johnson & Johnson
2020-03-11 Chairman and Chief Executive Officer, Johnson & Johnson
2021-03-10 Chairman and Chief Executive Officer, Johnson & Johnson.

JPMORGAN CHASE & CO

Filing Date Source Excerpt
2025-04-07 Alex Gorsky Retired Chairman and Chief Executive Officer of Johnson & Johnson Age: 64 Director since: 2022 Committees: Audit Committee Public Responsibility Committee 2024 Director compensation table Alex Gorsky $130,000 fees earned in cash, $265,000 stock award, $20,000 other fees, total $415,000.

Data sourced from SEC filings. Last updated: 2025-07-01